prof. dr hab. Gabriel Nowak

prof. dr hab. Gabriel Nowak

+48 12 6623215
pokój Ojcowska
Zakład Neurobiologii

Dokonania naukowe

  • Publikacje

Repeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in Mice

Autorzy: Patrycja Pańczyszyn-Trzewik, Katarzyna Stachowicz, Paulina Misztak, Gabriel Nowak, Magdalena Sowa-Kućma

DOI: 10.3390/ph17060762
Date: 2024-06-11

Zinc Deficiency Blunts the Effectiveness of Antidepressants in the Olfactory Bulbectomy Model of Depression in Rats

Autorzy: Anna Rafało-Ulińska, Bartłomiej Pochwat, Paulina Misztak, Ryszard Bugno, Agata Kryczyk-Poprawa, Włodzimierz Opoka, Bożena Muszyńska, Ewa Poleszak, Gabriel Nowak, Bernadeta Szewczyk

DOI: 10.3390/nu14132746
Date: 2022-06-30

Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy—The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene

Autorzy: Urszula Doboszewska, Jan Sawicki, Adam Sajnóg, Aleksandra Szopa, Anna Serefko, Katarzyna Socała, Mateusz Pieróg, Dorota Nieoczym, Katarzyna Mlyniec, Gabriel Nowak, Danuta Barałkiewicz, Ireneusz Sowa, Piotr Wlaź

DOI: 10.3390/cells11131987
Date: 2022-06-21

Antidepressant-like Effects of Combined Fluoxetine and Zinc Treatment in Mice Exposed to Chronic Restraint Stress Are Related to Modulation of Histone Deacetylase

Autorzy: Paulina Misztak, Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Bernadeta Szewczyk, Gabriel Nowak

DOI: 10.3390/molecules27010022
Date: 2021-12-21

Pharmaco-Electroencephalography-Based Assessment of Antidepressant Drug Efficacy-The Use of Magnesium Ions in the Treatment of Depression.

Autorzy:

DOI: 10.3390/jcm10143135
Date: 2021-07-15

Vorinostat (SAHA) May Exert Its Antidepressant-Like Effects Through the Modulation of Oxidative Stress Pathways

Autorzy: Paulina Misztak, Magdalena Sowa-Kućma, Bernadeta Szewczyk, Gabriel Nowak

DOI: 10.1007/s12640-020-00317-7
Date: 2021-04-01

GPCR oligomerization as a target for antidepressants: Focus on GPR39.

Autorzy:

DOI: 10.1016/j.pharmthera.2021.107842
Date: 2021-03-18

Synthesis of Novel Pyrido[1,2-<i>c</i>]pyrimidine Derivatives with 6-Fluoro-3-(4-piperidynyl)-1,2-benzisoxazole Moiety as Potential SSRI and 5-HT<sub>1A</sub> Receptor Ligands.

Autorzy:

DOI: 10.3390/ijms22052329
Date: 2021-02-26

Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depression.

Autorzy:

DOI: 10.1016/j.brainresbull.2021.02.003
Date: 2021-02-04

Targeting zinc metalloenzymes in coronavirus disease 2019

Autorzy: Urszula Doboszewska, Piotr Wlaź, Gabriel Nowak, Katarzyna Młyniec

DOI: 10.1111/bph.15199
Date: 2020-11-01

Zobacz także